Stock Screener App

無料 -

インストール

0.00

100.00% -12.00

Finch Therapeutics Group Inc (FNCH)

概要ニュース株価時系列 Financials ディスカッション予測株式分割

Finch Therapeutics Group Inc (FNCH) 最新ニュース

Finch Therapeutics: We Will Get A Healthy Premium (FNCHQ) - Seeking Alpha

Clostridium Difficile Infections Pipeline Set - openPR.com

Microbiome Therapeutics Market is Going to Booming Growth - openPR.com

Fecal Microbiota Transplantation (FMT) Market Overview, Key Trends, and Major Player Analysis - openPR.com

Global Factors Influencing the Rapid Evolution of the Difficile-Associated Diarrhea Treatment Market - openPR.com

Autism Spectrum Disorder Clinical Trial Pipeline Gains Momentum: 18+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight - Barchart.com

Finch Therapeutics Group Inc (FNCH) - Minichart

Microbiome Therapeutics Market Size, Share | Forecast [2034] - Fortune Business Insights

Finch Therapeutics Gr Stock Short Interest Report | OTC:FNCHQ - Benzinga

Clostridium Difficile Infections Treatment Pipeline Shows Strong Momentum as 20+ Pharma Companies in the Race | DelveInsight - Barchart

Clostridium Difficile Infections Treatment Pipeline Shows - openPR.com

Price Performance - Yahoo! Finance Canada

Finch Therapeutics Group, Inc. (FNCHQ) Insider Ownership & Holdings - Yahoo! Finance Canada

Finch Therapeutics Group, Inc. (FNCHQ) Balance Sheet - Yahoo! Finance Canada

Finch Therapeutics Group, Inc. (FNCHQ) Income Statement - Yahoo! Finance Canada

What date does Finch Therapeutics Group's (FNCHQ) report EarningsEarnings Calendar & Announcement - Zacks Investment Research

FNCHQ: Finch Therapeutics GroupComparative Chart - Zacks Investment Research

Dividend HistoryFinch Therapeutics Group (FNCHQ) - Zacks Investment Research

What is the current Price Target and Forecast for Finch Therapeutics Group (FNCHQ) - Zacks Investment Research

Finch Therapeutics Group (FNCHQ) Total Assets (Quarterly) - Zacks Investment Research

Finch Therapeutics Group (FNCHQ) Revenue (Quarterly) - Zacks Investment Research

Finch Therapeutics Group (FNCHQ) Return On Assets (TTM) - Zacks Investment Research

Return on invested capital % of Finch Therapeutics Group, Inc. – OTC:FNCHQ - TradingView

Price to book ratio of Finch Therapeutics Group, Inc. – OTC:FNCHQ - TradingView

Discontinued operations of Finch Therapeutics Group, Inc. – OTC:FNCHQ - TradingView

Diluted shares outstanding of Finch Therapeutics Group, Inc. – OTC:FNCHQ - TradingView

Long term debt to total equity ratio of Finch Therapeutics Group, Inc. – OTC:FNCHQ - TradingView

FNCHQ : Finch Therapeutics Group Key Company Details - Zacks Investment Research

Finch Therapeutics Group, Inc. Balance Sheet – OTC:FNCHQ - TradingView

Finch Therapeutics Group, Inc. Statistics – OTC:FNCHQ - TradingView

Return on assets % of Finch Therapeutics Group, Inc. – OTC:FNCHQ - TradingView

Finch Therapeutics Group, Inc. Cash Flow – OTC:FNCHQ - TradingView

Operating cash flow per share of Finch Therapeutics Group, Inc. – OTC:FNCHQ - TradingView

Finch Therapeutics Group, Inc. Earnings and Revenue – OTC:FNCHQ - TradingView — Track All Markets

Finch Therapeutics Group, Inc. Income Statement – OTC:FNCHQ - TradingView

Finch Therapeutics Group, Inc. Financial Statements – OTC:FNCHQ - TradingView

Finch Therapeutics Group (FNCHQ) Return On Equity (TTM) - Zacks Investment Research

Technical Analysis of Finch Therapeutics Group, Inc. (OTC:FNCHQ) - TradingView

Basic earnings per share (basic EPS) of Finch Therapeutics Group, Inc. – OTC:FNCHQ - TradingView

Finch Therapeutics Group (FNCHQ) Gross Profit (TTM) - Zacks Investment Research

Finch Therapeutics Group (FNCHQ) Cash From Operations (TTM) - Zacks Investment Research

Finch Therapeutics Group (FNCH) Expected to Announce Quarterly Earnings on Friday - Defense World

FNCHQ Stock Price and Chart — OTC:FNCHQ - TradingView

Finch Therapeutics Group (FNCHQ) Net Income (TTM) - Zacks Investment Research

All News for FNCHQ : Finch Therapeutics Group - Zacks Investment Research

FNCHQ (Finch Therapeutics Group) PB Ratio : 0.97 (As of Mar. 26, 2026) - GuruFocus

Meet The Attys In Biotech Biz Finch's Ch. 11 - Law360

Fecal Treatment Co. Says Ch. 11 Is Best Option To Sell Assets - Law360

Finch Therapeutics Group (FNCHQ) Pe Ratio (TTM) - Zacks Investment Research

Catching Up With New Bankruptcy Case Action - Law360

Fecal Treatment Co. Files Ch. 11 To Escape Lease, Sell IP - Law360

Weekly Bankruptcy Alert March 23, 2026 (For the Week Ending March 22, 2026) - The National Law Review

Boston Biotech Company Files for Chapter 11 Amid Financial Reorganization - WhatNow

Boston biotech company files for Chapter 11 amid financial reorganization - MSN

Emergent Capital (OTCMKTS:EMGCQ) Trading Down 6.5% – Time to Sell? - Defense World

Finch Therapeutics Group (NASDAQ:FNCH) Stock Price Down 2.7% – Here’s What Happened - Defense World

Canadian Critical Minerals Inc. (OTCMKTS:RIINF) Short Interest Update - Defense World

Top Space Stocks To Watch Today – March 17th - Defense World

Cardlytics revenue 2020 to 2024 - Statista

Clostridium Difficile Infections Pipeline 2026: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approvals by DelveInsight | Novartis AG, Astellas Pharma, Eli Lilly, AstraZeneca - Barchart.com

Mapping the microbiome patent ecosystem: An era of evolving innovation and complexity - Nixon Peabody

FNCH Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Finch Therapeutics Group (NASDAQ:FNCH) Trading Up 0.6% – Should You Buy? - Defense World

MRNA

$51.76

5.78%

RPRX

$50.15

0.81%

BNTX

$96.68

2.09%

INSM

$124.45

8.95%

RVMD

$148.62

1.89%

ONC

$315.13

0.42%

Yahooで開く | Google で開く | Finviz で開く | マーケットウォッチで開く | ロイターで開く